Published financial brief
0071B
AYR WELLNESS INC
- As of
- 2024-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 | FY 20242024-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 155.1 | 357.6 | 465.6 | 463.6 | 463.6 |
| Cost of goods soldUSD millions | 47.4 | 156.8 | 230.5 | 218.6 | 246.3 |
| Selling, general and administrative expenseUSD millions | 69.1 | 144.1 | 221.9 | 177.6 | 167 |
| Depreciation and amortizationUSD millions | 18.4 | 58.9 | 93 | 91.1 | 86.4 |
| Net incomeUSD millions | -176.3 | -17 | -245.5 | -86.1 | -359.3 |
| Operating profit (EBIT)USD millions | 20.2 | -2.1 | -79.7 | -23.7 | -36.1 |
| Income taxesUSD millions | 24.4 | 29.3 | 45.4 | 47.4 | 43.3 |
| Short-term debtUSD millions | 9.5 | 15.5 | 58.7 | 42.7 | 42 |
| Long-term debtUSD millions | 181.1 | 468.3 | 599.1 | 593.3 | 579.9 |
| Cash and equivalentsUSD millions | 127.2 | 154.3 | 80.6 | 50.8 | 35.5 |
| ReceivablesUSD millions | 3.6 | 7.4 | 8.9 | 13.5 | 13.2 |
| InventoryUSD millions | 40.3 | 93.4 | 115.1 | 106.4 | 112.6 |
| PayablesUSD millions | 8.9 | 27 | 28.5 | 24.8 | 30.9 |
| Net property, plant and equipmentUSD millions | 91.7 | 381.5 | 509.1 | 478.3 | 469.7 |
| Capital expenditureUSD millions | 14.4 | 100 | 62.5 | 27.7 | 17.7 |
| Operating cash flowUSD millions | 36.5 | -27.8 | -34.2 | 27.2 | 9.6 |
| Prepaid expensesUSD millions | —missing | —missing | —missing | —missing | —missing |
| AccrualsUSD millions | 8.7 | 40.3 | 29.4 | 42.9 | 28.3 |
| EBITDAUSD millions | 38.6 | 56.8 | 13.3 | 67.4 | 50.4 |
| Working capitalUSD millions | 118.7 | 113.7 | -15.5 | -7.3 | 65.8 |
| Working capital requirementUSD millions | 35 | 73.8 | 95.5 | 95.1 | 94.9 |
| Total debtUSD millions | 190.6 | 483.8 | 657.8 | 636 | 621.9 |
| Free cash flowUSD millions | 22.1 | -127.8 | -96.7 | -0.5 | -8.1 |
| Unlevered free cash flowUSD millions | 1.8 | -79.9 | -70.9 | 40.1 | 32.8 |
| Returns and ratios | |||||
| ROICratio | 3.6% | 0% | -4.6% | -1.6% | -3.1% |
| Pre-tax ROICratio | 3.6% | -0.1% | -4.6% | -1.6% | -3.1% |
| Effective tax rateratio | 0% | 100% | 0% | 0% | 0% |
| Revenue growthratio | 106.3% | 130.6% | 30.2% | -0.4% | 0% |
| EBIT / Revenueratio | 13% | -0.6% | -17.1% | -5.1% | -7.8% |
| Revenue / Invested capitalmultiple | 0.28× | 0.19× | 0.27× | 0.32× | 0.39× |
| Cogs Over Revenuesratio | 30.6% | 43.8% | 49.5% | 47.1% | 53.1% |
| Sga Over Revenuesratio | 44.5% | 40.3% | 47.6% | 38.3% | 36% |
| Da Over Revenuesratio | 11.9% | 16.5% | 20% | 19.7% | 18.6% |
| Nfa Over Revenuesratio | 59.1% | 106.7% | 109.3% | 103.2% | 101.3% |
| Wcr Over Revenuesratio | 22.6% | 20.6% | 20.5% | 20.5% | 20.5% |
| Debt Over Ebitdamultiple | 4.94× | 8.52× | 49.38× | 9.43× | 12.35× |
| St Debt Over Cashmultiple | 0.07× | 0.1× | 0.73× | 0.84× | 1.18× |
| Interest Over Ebitdamultiple | 0.19× | 0.46× | 3.61× | 0.78× | 1.73× |
| Interest Over Nocf Nicfmultiple | 0.34× | -0.2× | -0.5× | -98.57× | -10.78× |
| Nsf Over Wcrmultiple | -3.36× | -1.88× | -0.23× | -0.08× | 0.07× |
Ask this snapshot
Research assistant
0071B · annualSnapshot 6c0d7b23
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000